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Abstract
Introduction: Influenza is easily overlooked in intensive care units (ICUs), particularly in patients with alternative
causes of respiratory failure or in those who acquire influenza during their ICU stay.
Methods: We performed a prospective study of patients admitted to three adult ICUs of our hospital from
December 2010 to February 2011. All tracheal aspirate (TA) samples sent to the microbiology department were
systematically screened for influenza. We defined influenza as unsuspected if testing was not requested and the
patient was not receiving empirical antiviral therapy after sample collection.
Results: We received TA samples from 105 patients. Influenza was detected in 31 patients and was classified as
unsuspected in 15 (48.4%) patients, and as hospital acquired in 13 (42%) patients. Suspected and unsuspected
cases were compared, and significant differences were found for age (53 versus 69 median years), severe
respiratory failure (68.8% versus 20%), surgery (6.3% versus 60%), median days of ICU stay before diagnosis (1 versus
4), nosocomial infection (18.8% versus 66.7%), cough (93.8% versus 53.3%), localized infiltrate on chest radiograph
(6.3% versus 40%), median days to antiviral treatment (2 versus 9), pneumonia (93.8% versus 53.3%), and acute
respiratory distress syndrome (75% versus 26.7%). Multivariate analysis showed admission to the surgical ICU (odds
ratio (OR), 37.1; 95% confidence interval (CI), 2.1 to 666.6; P = 0.01) and localized infiltrate on chest radiograph (OR,
27.8; 95% CI, 1.3 to 584.1; P = 0.03) to be independent risk factors for unsuspected influenza. Overall mortality at 30
days was 29%. ICU admission for severe respiratory failure was an independent risk factor for poor outcome.
Conclusion: During the influenza season, almost one third of critical patients with suspected lower respiratory tract
infection had influenza, and in 48.4%, the influenza was unsuspected. Lower respiratory samples from adult ICUs
should be systematically screened for influenza during seasonal epidemics.
Introduction
Influenza is a common cause of admission to the inten-
sive care unit (ICU) during the influenza season and
influenza pandemics [1-4]. However, it may be over-
looked, particularly in patients with clinical manifesta-
tions that can be explained by alternative infectious or
noninfectious causes [5]. Furthermore, influenza may
not be suspected when respiratory function deteriorates
or fails in patients already admitted to the ICU.
At present, information on influenza acquired during
ICU stay is scarce and incomplete [5]. Timely knowl-
edge of the presence of influenza virus in patients
admitted to the ICU has obvious epidemiologic, diag-
nostic, and therapeutic advantages [4].
We assessed the burden of influenza in adult ICUs
and the number of overlooked cases when the routine
diagnostic workup was applied during the influenza sea-
son. We screened all tracheal aspirates sent to the
microbiology department for the diagnosis of lower
respiratory tract infection, even when not requested by
the attending physician.
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Materials and methods
Setting
Our hospital is a 1,550-bed tertiary referral teaching insti-
tution caring for a population of approximately 750,000
inhabitants. It has three different adult ICUs (medical, sur-
gical, and cardiac surgery) with a total of 42 beds.
Design
From December 15, 2010, through February 28, 2011, all
tracheal aspirate (TA) samples obtained from adult
patients (≥18 years) admitted to our ICUs and sent to the
microbiology department were systematically screened for
influenza virus.
ICU admission criteria and management for all patients,
including the need for intubation and for obtaining TA
samples, were not standardized, and decisions were made
at the discretion of the attending physician.
Patients with laboratory-confirmed influenza, by real-
time reverse transcriptase polymerase chain reaction
(RT-PCR) on TA and nasopharyngeal samples, were
prospectively followed up by an infectious diseases spe-
cialist and treated with oseltamivir, 150 mg/day, for 5 to
10 days. Clinical and microbiology data were recorded
in a preestablished protocol and entered into a database.
The study was approved by the ethics committee of
the “Fundación para la Investigación Biomédica del Hos-
pital Gregorio Marañón.” The requirement for informed
consent was waived because we applied an excellent
diagnostic technique to improve the quality of patient
care without any negative impact.
Our objectives were to determine the incidence of
influenza among adult ICU patients with a TA sample
obtained during the influenza season, and to demon-
strate the frequency of unsuspected cases and the rate
of hospital-acquired episodes.
Data collected
The variables recorded were age, sex, classification of
the severity of underlying conditions according to the
Charlson comorbidity index [6], type of ICU, date and
cause of ICU admission, APACHE II score [7] on
admission to the ICU, date of onset of influenza symp-
toms, clinical manifestations and radiologic findings at
diagnosis, date of TA sample collection, other samples
tested for influenza and result, date of initiation of anti-
viral treatment, complications (septic shock, acute
respiratory distress syndrome (ARDS)), outcome includ-
ing mortality within 30 days after influenza diagnosis,
and length of ICU and hospital stay.
Definitions
We defined the diagnosis of influenza as unsuspected
when influenza testing was not explicitly requested or
had not been previously requested in other samples,
such as nasopharyngeal swabs, and the patient was not
receiving empirical antiviral treatment immediately after
sample collection.
Influenza was classified as community acquired if the
flu syndrome (fever, chills, malaise, sore throat, rhinor-
rhea, cough, dyspnea, myalgia, nausea, and diarrhea)
began before or during the first 72 hours of hospital
admission. The infection was classified as hospital-
acquired, if symptoms started after the first 72 hours [8].
As for causes of ICU admissions, severe respiratory
failure was defined as severe hypoxemia (PaO2 < 60 mm
Hg) refractory to high-flow oxygen therapy (FiO2, 50%)
with a Venturi mask.
As for underlying conditions, chronic obstructive pul-
monary disease was defined according to the criteria of
the 2007 Global Initiative for Chronic Obstructive Lung
Disease [9]. Immunosuppressed patients were those with
hematologic malignancy (with or without bone marrow
transplantation), HIV infection, inflammatory diseases
under biologic or immunosuppressive treatment and
solid organ transplant. As for influenza vaccination, we
considered patients who had been vaccinated against
influenza within 6 months before admission.
Pneumonia was defined according to the current
IDSA/ATS guidelines [10]. ARDS and septic shock were
defined by using standard criteria [11,12].
Microbiologic procedures
Samples for microbiologic diagnosis were taken by
endotracheal aspiration with a 14F sterile probe to a
depth of 2 cm from the distal end of the endotracheal
tube. The secretions obtained were collected in a sterile
container (Lukens Specimen Container; Sherwood Medi-
cal, Tullamore, Ireland) and transported in sterile
packages to the microbiology laboratory for Gram stain-
ing and bacterial and viral procedures.
Standard bacterial procedures included quantitative
culture performed on blood agar, chocolate agar,
McConkey agar, and, when required, Legionella agar
(BCYE) [13]. Positive samples were defined as those
with bacterial counts ≥105 cfu/ml of each significant
microorganism. The microorganisms were identified and
antimicrobial susceptibility testing performed by using
an automatic system (MicroScan; Dade Behring, Sacra-
mento, CA, USA). Breakpoints were determined after
the Clinical and Laboratory Standards Institute (CLSI)
guidelines [14]. Unless proven otherwise, we considered
as nonpathogenic the isolation (at any concentration) of
the following microorganisms: viridans-group strepto-
cocci, Enterococcus spp., coagulase-negative Staphylococ-
cus, Neisseria spp., Corynebacterium spp., and Candida
spp.
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Samples were collected in viral-transport medium
(Copan 305C; Copan Innovation, Brescia, Italy). A 200-
μl aliquot was stored at 4°C for no longer than 48 hours
until analysis. The rest of the sample was stored at -80°
C for further amplification and sequencing.
RNA was extracted in a Nuclisens EasyMAG system
(BioMérieux, Boxtel, The Netherlands) by following the
manufacturer’s instructions. Pandemic influenza A
pH1N1 was detected by real-time reverse transcriptase
polymerase chain reaction (RT-PCR) by following the
WHO/CDC protocol in a Stratagene MX3000 thermo-
cycler (Stratagene, La Jolla, CA, USA). Those samples
rendering indeterminate results (low-fluorescence signal
or high Ct values) were tested again with the RealTime
ready Inf A/H1N1 Detection Set (Roche Diagnostics,
Mannheim, Germany). Influenza B was detected by
using the RealTime ready Influenza B Detection Set
(Roche Diagnostics). H3N2 and seasonal H1N1 strains
were detected as described elsewhere [15].
Relative DNA was quantified by combining the RT-
PCR methods described with the detection of a house-
keeping gene with real-time RT-PCR, as described by
the CDC. This method allowed normalization of the
initial amount of RNA present in each sample [16].
Statistical analysis
Categoric variables appear with their frequency distribu-
tion. Nonnormally distributed continuous variables are
expressed as the median and interquartile range (IQR).
The association between categoric variables was evalu-
ated by using the c2 test or Fisher Exact test; the asso-
ciation between continuous variables was evaluated by
using the Mann-Whitney U test.
A logistic binary model was used to analyze the indepen-
dent risk factors for unsuspected influenza and 30-day
mortality. Variables with P ≤ 0.1 in the univariate analysis
were entered into the multivariate model. The level of sig-
nificance was set at P < 0.05 for all the tests. The statistical
analysis was performed by using SPSS 13.0.
Results
During the study period, 618 patients were admitted to
our adult ICUs. Overall, one or more TA samples were
obtained from 105 patients, and a microbiologic diagno-
sis was made in 65 of them (see Figure 1). Bacterial infec-
tion was diagnosed in 29 patients, and the frequencies of
the pathogens isolated were as follows: Staphylococcus
aureus, 37.9%; Enterobacteriaceae, 24.1%; Pseudomonas
aeruginosa, 17.2%; Streptococcus pneumoniae, 13.7%; and
Acinetobacter baumannii, 6.8%. A diagnosis of viral
infection only was made in 25 patients: 23 with influenza
virus, one with adenovirus, and one with herpes simplex
virus. Aspergillus fumigatus was the only microorganism
isolated in three patients. The remaining eight patients
initially had coinfection with influenza virus and the fol-
lowing microorganisms: S. aureus, three; S. pyogenes, one;
S. pneumoniae, one; A. baumannii, one; P. aeruginosa,
one; and Aspergillus fumigatus, one.
Incidence and clinical characteristics of patients with
influenza
During the study period, the overall incidence of influenza
in the adult ICUs of our hospital was 5.3 cases per 100
ICU admissions. The incidence of influenza among the
patients with at least one TA sample sent to the micro-
biology department was 29.5 cases per 100 ICU patients.
The reasons for admission to the ICU and the charac-
teristics and outcome of the 31 patients with influenza
are shown in Table 1. Influenza was unsuspected in 15
(48.4%) patients and hospital-acquired in 13 (42%)
patients. At the time of influenza diagnosis, all patients
but one were intubated.
Among patients with co-infection, the reasons for
admission to the ICU were as follows: surgery, five;
respiratory failure, one; cardiac arrest, one; and decom-
pensated cirrhosis, one. Influenza was classified as hos-
pital acquired in five (62.5%) of them, and pneumonia
was diagnosed in seven (87.5%) patients.
Microbiologic characteristics
Overall, viral infection was diagnosed in 33 patients, and
in 31 (93.9%) of them, influenza was detected. Influenza
was due to the 2009 pandemic influenza A H1N1 strain
in 27 (87%) patients, influenza B in three (9.7%) patients,
and influenza A H3N2 in one (3.2%) patient.
In 17 of the 31 patients, influenza testing was per-
formed simultaneously in the TA and nasopharyngeal
samples. The upper respiratory tract sample failed to
detect influenza in 17.6% of cases.
Overall, the median relative viral load at diagnosis was
1.55 (IQR, 0.68 to 3.16). This tended to be higher in
patients with suspected influenza (Table 2).
Comparison of suspected and unsuspected cases
Patients with suspected influenza were compared with
those with unsuspected influenza (Table 2). The univari-
ate analysis revealed significant differences for age (53
versus 69 years; P = 0.008), medical ICU (93.8% versus
40%; P = 0.002), admission to the ICU for severe
respiratory failure (68.8% versus 20%; P = 0.002), length
of ICU stay before the influenza diagnosis (1 (IQR, 0 to
1) versus 4 (IQR, 1 to 17) days; P = 0.01), classification
as having hospital-acquired influenza (18.8% versus
66.7%; P = 0.01), cough (93.8% versus 53.3%; P = 0.01),
localized pulmonary infiltrate on radiograph (6.3% ver-
sus 40%; P = 0.04), median days to initiation of antiviral
therapy after onset of symptoms (2 (IQR, 2 to 6) versus
9 (IQR, 4.5 to 18) days; P = 0.02), pneumonia (93.8%
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versus 53.3%; P = 0.01), and development of ARDS (75%
versus 26.7%; P = 0.01). Mortality at 30 days after the
influenza diagnosis was 37.5% and 20% (P = 0.43) in
patients with suspected and unsuspected influenza,
respectively.
Multivariate analysis showed the independent risk fac-
tors associated with unsuspected influenza to be admis-
sion to the surgical ICU (OR, 37.13; 95%CI, 2.06 to
666.60; P = 0.01) and localized pulmonary infiltrate on
radiograph (OR, 27.78; 95%CI, 1.32 to 584.06; P = 0.03).
Longer ICU stay before the diagnosis of influenza was
also associated with unsuspected influenza but was not
significant (Table 3).
Outcome
Overall mortality at 30 days after influenza diagnosis
was 29%. The univariate analysis of the risk factors for
mortality is shown in Table 4. Nosocomial acquisition
of influenza was associated with better outcome (54.5%
versus 11.1%; P = 0.04). The only independent risk fac-
tor for 30-day mortality in the multivariate analysis was
severe respiratory failure as the reason for admission to
the ICU (OR, 7.5; 95%CI, 1.23 to 45.8; P = 0.03).
Discussion
During the influenza season, almost one third of
patients hospitalized in our adult ICUs and with
suggestion of lower respiratory tract infection had influ-
enza. Influenza was unsuspected in 48.4% and hospital
acquired in 42%. Patients with unsuspected influenza
were more frequently admitted to the ICU for surgery,
had a localized infiltrate on chest radiograph, and stayed
longer in the ICU before being diagnosed with influenza.
Antiviral treatment was initiated later in patients with
unsuspected influenza, although mortality was similar in
both groups. Overall mortality at 30 days after the influ-
enza diagnosis was 29%; however, it was lower in
patients with nosocomial influenza. Severe respiratory
failure as the cause of admission to the ICU was the
only independent factor associated with poor outcome.
Acute febrile respiratory illness is a common cause of
respiratory failure and admission to the ICU [2-4]. In
most cases, the etiology is bacterial, although viruses
have been implicated in almost 9% of cases [17]. During
the 2009 pandemic, the rate of ICU admission for
respiratory failure among hospitalized patients with a
confirmed diagnosis of influenza A (H1N1v) ranged
from 15% to 34% [18-22]. However, no studies have
investigated the rates of bacterial and viral etiologies
among patients admitted to the ICU with suggestion of
lower respiratory tract infection during the 2009 pan-
demic. Here, we demonstrated that, after the pandemic
influenza season, the etiology was viral in 31.4% of
patients admitted to the ICU with suggestion of lower
Patients with a microbiological diagnosis:
65
Mixed infection = 8
- Influenza + bacteria = 7 (3 community-
acquired, 4 hospital-acquired)
- Influenza + fungi = 1 (hospital-acquired)
Patients admitted to the adult ICUs of our hospital 
during the study period:
618
Patients with at least one TA sample sent to the 
microbiology department for suspicion of lower 
respiratory tract infection:
Virus only = 25
- Influenza = 23 (16 community-
acquired, 7 hospital-acquired)





Patients with no significant 
microorganisms isolated:
40
Figure 1 Flow diagram of study patients. ICU, intensive care unit; TA, tracheal aspirate.
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respiratory tract infection. Influenza was detected in
most of these cases (93.9%).
The etiology of acute febrile respiratory illness causing
respiratory failure is often unknown at admission to the
ICU [17]. About half of the cases are diagnosed as bac-
terial pneumonia shortly after admission, with a small
number of cases found to be viral pneumonia when the
initial bacterial studies are negative [10]. Detection of
influenza virus often depends on specific epidemiologic
risk factors and clinical suspicion. The combination of
fever, malaise, and cough was shown to have a 79%
positive predictive value during the pandemic and seaso-
nal epidemics [23,24]; however, these criteria may be
not accurate in ICU patients, because other etiologies,
or conditions like as postsurgery sedation, may
confound the diagnosis [25]. In our study, influenza was
unsuspected in 48.4% of cases. Suspicion of influenza
was lower in older patients, in those admitted to the
ICU for surgical conditions, in those who stayed for a
Table 1 Characteristics of ICU patients diagnosed with
influenza
n = 31 (%)
Demographic data
Age (years) (median, IQR) 64, 48-70




Reason for admission to the ICU
Severe respiratory failure 14 (45.1)
Surgery 10 (32.2)
Cardiac arrest 4 (12.9)
Othera 3 (9.6)
APACHE II score 15, 12-17
Characteristics of influenza







Unsuspected infection 15 (48.4)






Septic shock 13 (41.9)
ARDS 16 (51.6)
30-day mortality 9 (29)
aAcute hepatic failure (one patient), necrotizing pancreatitis (one patient), and
decompensated cirrhosis (one patient). ARDS, acute respiratory distress
syndrome; ICU, intensive care unit; IQR, interquartile range.
Table 2 Comparison of patients with suspected and
unsuspected influenza
Suspected Unsuspected P
n = 16 (%) n = 15 (%)
Demographic data
Age (years) (median, IQR) 53, 42-66 69, 60-79 0.008
Male sex 11 (68.8) 9 (60) 0.71
Underlying conditions
COPD 7 (43.8) 7 (46.7) 1
Immunosuppression 3 (18.8) 2 (13.3) 1
Charlson score 4.5, 2.2-7 6, 3-9 0.26
Influenza vaccination 4 (25) 3 (20) 1
Type of ICU
Medical 15 (93.8) 6 (40) 0.002
Surgical 1 (6.3) 9 (60)
Reason for admission to the ICU
Severe respiratory failure 11 (68.8) 3 (20) 0.002
Surgery 1 (6.3) 9 (60)
Cardiac arrest 3 (18.8) 1 (6.7)
Other 1 (6.3) 2 (13.3)




Days of symptoms before
diagnosisa
3, 1-6.7 5, 0-9 0.92
Days of ICU stay before
diagnosisa
1, 0-1 4, 1-17 0.01
Days of hospital stay before
diagnosisa
2.50, 1-5.75 15, 5-22 0.008
Hospital acquired 3 (18.8) 10 (66.7) 0.01
Fever 11 (68.8) 11 (73.3) 1
Cough 15 (93.8) 8 (53.3) 0.01
Dyspnea 13 (81.3) 11 (73.3) 0.68
Pneumonia 15 (93.8) 8 (53.3) 0.01
Localized infiltrate on chest
radiograph
1 (6.3) 6 (40) 0.04





Days to antiviral treatmenta 2, 2-6 9, 4.5-18 0.02
Co-infection 3 (18.8) 5 (33.3) 0.43
Outcome
Septic shock 8 (50) 5 (33.3) 0.47
ARDS 12 (75) 4 (26.7) 0.01
30-day mortality 6 (37.5) 3 (20) 0.43
Days of ICU stay (median, IQR) 11, 4-33 27, 8-50 0.21
Days of hospital stay (median,
IQR)
39, 4-46 66, 30-90 0.06
aVariables are expressed as median and interquartile range. ARDS, acute
respiratory distress syndrome; COPD, chronic obstructive pulmonary disease;
ICU, intensive care unit; IQR, interquartile range.
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longer time in hospital and ICU, and in those who did
not have a cough and diffuse pulmonary infiltrates. The
direct consequence of overlooked influenza was a signif-
icant delay in the initiation of antiviral treatment.
Definitive diagnosis of influenza is by detection of the
virus in culture or RT-PCR with a nasopharyngeal aspi-
rate/swab or lower respiratory tract sample [23,24].
Because viral shedding peaks at 48 hours after the onset
of illness and declines thereafter, testing of lower respira-
tory tract samples in patients with compromised lung
parenchyma may be more beneficial [23,26,27]. Accord-
ingly, we found that the upper respiratory tract sample
did not reveal influenza in 17.6% of cases. Diagnostic
viral load tended to be higher in patients with suspected
influenza, possibly as a result of the earlier diagnosis of
influenza after onset of symptoms in this group com-
pared with patients with unsuspected influenza.
Hospital-acquired influenza is a well-recognized pro-
blem [28,29]. Nosocomial outbreaks of pandemic and
seasonal influenza have been documented in various set-
tings, including ICUs, pediatric wards, transplant units,
medical wards, and surgical wards [28-32]. However,
few sporadic cases of hospital-acquired influenza have
been reported during surveillance activities [33]. In a
study including 1,520 patients hospitalized with the pan-
demic 2009 influenza A in 75 hospitals in the United
Kingdom, the authors identified 30 (2%) cases of spora-
dic nosocomial influenza [33]. These comprised 15
adults and 15 children. Most had serious underlying ill-
nesses and were admitted to nonmedical areas, as in our
study. Unexpectedly, we found that the 30-day mortality
rate was lower in patients with hospital-acquired influ-
enza. This figure can be associated with viral factors,
such as lower virulence of the influenza strains circulat-
ing in the hospital, or with host factors, such as older
age and surgical conditions.
Overall, 30-day mortality was high (29%), and admis-
sion to the ICU for severe respiratory failure was an
independent risk factor for death. These data are consis-
tent with those of Martin-Loeches et al. [34], who
showed that patients from the postpandemic influenza
pH1N1 period had an unexpectedly high mortality rate.
Early administration of antiviral therapy has been asso-
ciated with better outcome in critically ill patients [35].
In our study, although the timing to initiation of anti-
viral treatment was longer among patients with unsus-
pected influenza, a trend to lower mortality was seen in
this group compared with patients with suspected influ-
enza. A possible explanation of this finding could be
that: suspected and unsuspected groups were epidemio-
logically very different, and the median relative viral
load was lower in the unsuspected group; thus, epide-
miologic and viral factors could influence the outcome
in the two groups independently of the timing of





Surgical ICU 37.13 (2.06-666.60) 0.01
Localized infiltrate on chest radiograph 27.78 (1.32-584.06) 0.03
Days of ICU stay before influenza diagnosis 1.31 (0.97-1.78) 0.07
CI, confidence interval; ICU, intensive care unit.
Table 4 Univariate analysis of risk factors for 30-day
mortality
Survivors Nonsurvivors P
n = 22 (%) n = 9 (%)
Demographic data
Age (years) (median, IQR) 66.5, 57.7-
75.5
54, 43-62 0.09
Male sex 15 (68.2) 5 (55.6) 0.68
Underlying conditions
Immunosuppression 4 (18.2) 1 (11.1) 1
COPD 9 (40.9) 5 (55.6) 0.69
Charlson score 6, 2-8 5, 3.5-6.5 0.65
Influenza vaccination 5 (22.7) 2 (22.2) 1
Type of ICU
Medical 13 (59.1) 8 (88.9) 0.20
Surgical 9 (40.9) 1 (11.1)
Reason for admission to the ICU
Severe respiratory failure 7 (31.8) 7 (77.8) 0.08
Surgery 9 (40.9) 1 (11.1)
Cardiac arrest 4 (18.2) 0
Other 2 (9.1) 1 (11.1)




Days of symptoms before
diagnosisa
3.5, 0-9 3, 1.5-5 0.87
Days of ICU stay before
diagnosisa
Unsuspected diagnosis 1, 0-14.5 1, 0-3 0.26
Hospital acquired 12 (54.5) 3 (33.3) 0.43
Fever 12 (54.5) 1 (11.1) 0.04
Cough 15 (68.2) 7 (77.8) 0.68
Dyspnea 14 (63.6) 9 (100) 0.07
Localized infiltrate on chest
radiograph
15 (68.2) 9 (100) 0.07
Viral load at diagnosis 4 (18.2) 3 (33.3) 0.64
Pneumonia 1.5, 0.3-2.4 1.8, 0.8-5.5 0.40
Co-infection 15 (68.2) 8 (88.9) 0.38
6 (27.3) 2 (22.2) 1
aVariables are expressed as median and interquartile range. COPD, chronic
obstructive pulmonary disease; ICU, intensive care unit; IQR, interquartile
range.
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antiviral treatment. Conversely, the benefit of testing will
not be necessarily to the patient in terms of improved
outcome due to early therapy, but more likely to pre-
venting the nosocomial transmission of influenza.
Our study is limited in that the small number and
heterogeneity of patients diminishes the power of our
data analysis. We performed the study during the post-
pandemic period (2010 to 2011), when the prevalence of
the pandemic influenza A H1N1 strain was still high.
Findings could vary between one influenza season and
another, depending on the characteristics of the preva-
lent influenza virus stain. We did not perform a cost-
effectiveness analysis, although the finding of a longer
ICU and hospital stay in patients with unsuspected
influenza suggests a potential favorable impact on care
management. We could not perform an analysis of the
possible routes of transmission of the nosocomial cases.
However, we can exclude with sufficient certainty the
occurrence of an outbreak for the following reasons: (a)
the cases of hospital-acquired influenza were distributed
uniformly between the three ICUs (postsurgery ICU, six;
medical ICU, five; and postcardiosurgery ICU, two); (b)
no case of influenza was recognized among the health-
care staff during the study period; (c) the preventive
measures included vaccination of staff, respiratory isola-
tion, and droplet-contact precautions, as recommended
by the Centers for Disease Control and Prevention [36].
Conclusions
We showed that influenza is a common cause of acute
respiratory illness among patients admitted to the ICU
during seasonal epidemics, and that it is often over-
looked, and it could lead to a delay in the initiation of
antiviral treatment and possible nosocomial transmission
of influenza.
Microbiology departments should systematically inves-
tigate the presence of influenza in respiratory samples
obtained from ICU patients during the seasonal
epidemic.
Key messages
• The incidence of influenza in the adult ICU during
the influenza season is high.
• The diagnosis of influenza is often overlooked in
ICU patients. Among patients with unsuspected
influenza, the timing to initiation of antiviral treat-
ment was longer, and the rate of hospital-acquired
influenza was higher compared with that of patients
with suspected influenza.
• Microbiology departments should systematically
investigate the presence of influenza in respiratory
samples obtained from ICU patients during the sea-
sonal epidemic.
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